Immix Biopharma Inc (IMMX) — Strategic Asset Allocation Index
Immix Biopharma Inc (IMMX) has a Strategic Asset Allocation Index of 0.9% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $2.05 Million) total $2.05 Million, measured against net assets of $228.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Immix Biopharma Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Immix Biopharma Inc Strategic Asset Allocation Index (2021–2022)
This chart shows how Immix Biopharma Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of June 2026, the index stands at 0.9%, representing strategic assets of $2.05 Million against net assets of $228.92 Million USD. For live market cap and overall valuation, see Immix Biopharma Inc market capitalisation.
Annual Strategic Asset Allocation Index for Immix Biopharma Inc (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Immix Biopharma Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Immix Biopharma Inc's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | $3.56K | $3.56K | $- | $13.16 Million | ▼ 0.0 pp |
| 2021 | 0.0% | $5.70K | $5.70K | $- | $17.99 Million | — |